Radiofrequency Ablation vs Conventional Surgery for Superficial Venous Insufficiency
Randomised Trial of Radiofrequency Ablation vs Conventional Surgery for Superficial Venous Insufficiency: if You Don't Tell, They Won't Know
1 other identifier
interventional
18
1 country
1
Brief Summary
The current study was a double blind randomised controlled trial that compared radiofrequency ablation (RFA) versus conventional surgery (CS) in patients who served as their own controls and who had intact great saphenous veins (GSVs).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 20, 2015
CompletedFirst Posted
Study publicly available on registry
October 28, 2015
CompletedOctober 28, 2015
October 1, 2015
1.5 years
October 20, 2015
October 26, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Change in intensity of hyper pigmentation using a scale of 0 to 10
Patients and physicians were oriented to indicate their subjective perception of intensity of hyperpigmentation on a scale of 0 (no complaint/discomfort) to 10 (maximal complaint/discomfort).
One week, one month and six months after surgery
Change in extension of hematoma using a scale of 0 to 10
Patients and physicians were oriented to indicate their subjective perception of extension of hematoma on a scale of 0 (no complaint/discomfort) to 10 (maximal complaint/discomfort).
One week, one month and six months after surgery
Change in aesthetic results using a scale of 0 to 10
Patients and physicians were oriented to indicate their subjective perception of aesthetic results on a scale of 0 (unaesthetic) to 10 (excellent results).
One week, one month and six months after surgery
Change in pain levels using a scale of 0 to 10
Patients were asked to indicate pain levels on a scale of 0 (no pain) to 10 (worst imaginable pain).
One week, one month and six months after surgery
Change in intensity of skin burns using a scale of 0 to 10
Physicians were asked to inform intensity of skin burns on a scale of 0 (no complaint/discomfort) to 10 (maximal complaint/discomfort).
One week, one month and six months after surgery
Change in presence of sensitivity alteration
Patients were asked to indicate the presence or absence of sensitivity alteration.
One week, one month and six months after surgery
Change in presence of thrombophlebitis
Physicians were asked to inform the presence or absence of thrombophlebitis.
One week, one month and six months after surgery
Change in presence of resection or occlusion of the great saphenous vein
Duplex ultrasound scan was used to evaluate the presence or absence of resection or occlusion (success rate) of the great saphenous vein.
One month, six months and 12 months after surgery
Change in presence of reflux in the sapheno-femoral junction and in the great saphenous vein
Duplex ultrasound scan was used to evaluate the presence or absence of reflux in the sapheno-femoral junction and in the great saphenous vein
One month, six months and 12 months after surgery
Change in presence of complications
Duplex ultrasound scan was used to evaluate the presence or absence of complications such as deep vein thrombosis (DVT) and lymphocele.
One month, six months and 12 months after surgery
Study Arms (2)
Conventional Surgery
ACTIVE COMPARATORLimb with GSV insufficiency in the same patient, randomised to conventional surgery
Radiofrequency Ablation
ACTIVE COMPARATORLimb with GSV insufficiency in the same patient, randomised to radiofrequency ablation
Interventions
Cranial ligation of the great saphenous vein and branches of the sapheno-femoral junction and stripping of the great saphenous vein
Catheter-based ablation of the great saphenous vein
Eligibility Criteria
You may qualify if:
- Age between 18 and 60 years
- Clinical, etiologic, anatomic, pathophysiologic (CEAP): clinical grades 2 to 5 (C2-5), primary (Ep), superficial (As) and reflux only (Pr)
- Duplex scan confirmed primary bilateral GSV insufficiency requiring surgery (insufficiency with reverse venous flow was regarded significant if persisting more than 0.5 seconds in a standing position)
You may not qualify if:
- Patients able to give informed consent
- Varicose veins without GSV insufficiency on duplex scan
- Previous varicose vein surgery
- Associated small saphenous vein reflux, duplication of the GSV at the SFJ, deep venous insufficiency or previous DVT on duplex scan
- GSV diameter \<3 mm or \>12 mm in the supine position
- Thrombus in the GSV
- Patients with a pacemaker or internal defibrillator
- Concomitant peripheral arterial disease (ankle-brachial pressure index of \<0.9)
- Patients on oral anticoagulants
- Patients with high blood pressure not controlled by medication
- Patients with known thrombophilia, cancer or lupus
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nelson Woloskerlead
Study Sites (1)
Hospital Israelita Albert Einstein
São Paulo, São Paulo, Brazil
Related Publications (6)
Wittens C, Davies AH, Baekgaard N, Broholm R, Cavezzi A, Chastanet S, de Wolf M, Eggen C, Giannoukas A, Gohel M, Kakkos S, Lawson J, Noppeney T, Onida S, Pittaluga P, Thomis S, Toonder I, Vuylsteke M, Esvs Guidelines Committee, Kolh P, de Borst GJ, Chakfe N, Debus S, Hinchliffe R, Koncar I, Lindholt J, de Ceniga MV, Vermassen F, Verzini F, Document Reviewers, De Maeseneer MG, Blomgren L, Hartung O, Kalodiki E, Korten E, Lugli M, Naylor R, Nicolini P, Rosales A. Editor's Choice - Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2015 Jun;49(6):678-737. doi: 10.1016/j.ejvs.2015.02.007. Epub 2015 Apr 25. No abstract available.
PMID: 25920631BACKGROUNDSiribumrungwong B, Noorit P, Wilasrusmee C, Attia J, Thakkinstian A. A systematic review and meta-analysis of randomised controlled trials comparing endovenous ablation and surgical intervention in patients with varicose vein. Eur J Vasc Endovasc Surg. 2012 Aug;44(2):214-23. doi: 10.1016/j.ejvs.2012.05.017. Epub 2012 Jun 15.
PMID: 22705163BACKGROUNDHinchliffe RJ, Ubhi J, Beech A, Ellison J, Braithwaite BD. A prospective randomised controlled trial of VNUS closure versus surgery for the treatment of recurrent long saphenous varicose veins. Eur J Vasc Endovasc Surg. 2006 Feb;31(2):212-8. doi: 10.1016/j.ejvs.2005.07.005. Epub 2005 Aug 31.
PMID: 16137898BACKGROUNDGoode SD, Chowdhury A, Crockett M, Beech A, Simpson R, Richards T, Braithwaite BD. Laser and radiofrequency ablation study (LARA study): a randomised study comparing radiofrequency ablation and endovenous laser ablation (810 nm). Eur J Vasc Endovasc Surg. 2010 Aug;40(2):246-53. doi: 10.1016/j.ejvs.2010.02.026.
PMID: 20537570BACKGROUNDSubramonia S, Lees T. Radiofrequency ablation vs conventional surgery for varicose veins - a comparison of treatment costs in a randomised trial. Eur J Vasc Endovasc Surg. 2010 Jan;39(1):104-11. doi: 10.1016/j.ejvs.2009.09.012. Epub 2009 Oct 29.
PMID: 19879166BACKGROUNDMendes CA, Martins AA, Fukuda JM, Parente JB, Munia MA, Fioranelli A, Teivelis MP, Varella AY, Caffaro RA, Kuzniec S, Wolosker N. Randomized trial of radiofrequency ablation versus conventional surgery for superficial venous insufficiency: if you don't tell, they won't know. Clinics (Sao Paulo). 2016 Nov 1;71(11):650-656. doi: 10.6061/clinics/2016(11)06.
PMID: 27982166DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nelson Wolosker, MD, PhD
Hospital Israelita Albert Einstein
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
October 20, 2015
First Posted
October 28, 2015
Study Start
November 1, 2013
Primary Completion
May 1, 2015
Study Completion
October 1, 2015
Last Updated
October 28, 2015
Record last verified: 2015-10